Medical News Interviews
More evidence for the benefits of aggressive lipid-lowering with statins has come from the IDEAL study, which randomised nearly 9000 post-MI patients to either 80 mg of atorvastatin or 20/40 mg simvastatin daily. Terje Pedersen from Ulleval University Hospital in Norway presented the findings.
[audio:https://www.audiomedica.com/podcasting/aha2005/Terje_Pedersen.mp3]
Click here for all the interviews from AHA 2005
GAUSS STUDY: New alternative for LDL lowering in patients intolerant to statins 16 Nov, 2012 
BNP Test: Key Diagnostic Step for Heart Failure (PEP Study) 3 Sep, 2007 Audio Journal of Cardiovascular Medicine: September 5th 2006 5 Sep, 2006 Torcetrapib in Patients at High Risk for Coronary Events: ILLUMINATE Trial Latest Results 6 Nov, 2007 
COVID-19 Co-Morbidity Risks Quantified from Three Continents SurveyMay 28, 2020
Ultrahypofractionated Radiation Just As Effective for Prostate CancerMay 16, 2018
First evidence that genome editing made patients with AIDS more resistant to HIVMarch 8, 2014Anticoagulation with warfarin can be beneficial in patients with atrial fibrillation and chronic kidney disease.March 7, 2014Prostate cancer: Adult exposure to bisphenol-A linked to prostate cancer riskMarch 6, 2014
